Report Detail
Global (United States, European Union and China) Nalbuphine HCL Market Research Report 2019-2025
- RnM3673317 |
- 16 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Nalbuphine HCL (Nalbuphine hydrochloride) is a narcotic pain reliever used to treat moderate to severe pain.Nubain is also used for treating pain just after surgery or childbirth.
In 2019, the market size of Nalbuphine HCL is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nalbuphine HCL.
This report studies the global market size of Nalbuphine HCL, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Nalbuphine HCL sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Acme
Dr Reddy's
Glenmark
Global Pharmaceuticals
HOSPIRA
Humanwell
Incepta Pharmaceuticals
Manusaktteva
Opsonin
Sami
Squarepharma
Market Segment by Product Type
Adult
Children
Market Segment by Application
Hospital
Pharmacy
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Nalbuphine HCL status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nalbuphine HCL manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Nalbuphine HCL are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Nalbuphine HCL Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Adult
- 1.3.3 Children
- 1.4 Market Segment by Application
- 1.4.1 Global Nalbuphine HCL Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Pharmacy
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Nalbuphine HCL Market Size
- 2.1.1 Global Nalbuphine HCL Revenue 2014-2025
- 2.1.2 Global Nalbuphine HCL Sales 2014-2025
- 2.2 Nalbuphine HCL Growth Rate by Regions
- 2.2.1 Global Nalbuphine HCL Sales by Regions 2014-2019
- 2.2.2 Global Nalbuphine HCL Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Nalbuphine HCL Sales by Manufacturers
- 3.1.1 Nalbuphine HCL Sales by Manufacturers 2014-2019
- 3.1.2 Nalbuphine HCL Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Nalbuphine HCL Revenue by Manufacturers (2014-2019)
- 3.2.2 Nalbuphine HCL Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Nalbuphine HCL Market Concentration Ratio (CR5 and HHI)
- 3.3 Nalbuphine HCL Price by Manufacturers
- 3.4 Key Manufacturers Nalbuphine HCL Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Nalbuphine HCL Market
- 3.6 Key Manufacturers Nalbuphine HCL Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Adult Sales and Revenue (2014-2019)
- 4.1.2 Children Sales and Revenue (2014-2019)
- 4.2 Global Nalbuphine HCL Sales Market Share by Type
- 4.3 Global Nalbuphine HCL Revenue Market Share by Type
- 4.4 Nalbuphine HCL Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Nalbuphine HCL Sales by Application
6 United States
- 6.1 United States Nalbuphine HCL Breakdown Data by Company
- 6.2 United States Nalbuphine HCL Breakdown Data by Type
- 6.3 United States Nalbuphine HCL Breakdown Data by Application
7 European Union
- 7.1 European Union Nalbuphine HCL Breakdown Data by Company
- 7.2 European Union Nalbuphine HCL Breakdown Data by Type
- 7.3 European Union Nalbuphine HCL Breakdown Data by Application
8 China
- 8.1 China Nalbuphine HCL Breakdown Data by Company
- 8.2 China Nalbuphine HCL Breakdown Data by Type
- 8.3 China Nalbuphine HCL Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Nalbuphine HCL Breakdown Data by Company
- 9.2 Rest of World Nalbuphine HCL Breakdown Data by Type
- 9.3 Rest of World Nalbuphine HCL Breakdown Data by Application
- 9.4 Rest of World Nalbuphine HCL Breakdown Data by Countries
- 9.4.1 Rest of World Nalbuphine HCL Sales by Countries
- 9.4.2 Rest of World Nalbuphine HCL Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Acme
- 10.1.1 Acme Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.1.4 Nalbuphine HCL Product Introduction
- 10.1.5 Acme Recent Development
- 10.2 Dr Reddy's
- 10.2.1 Dr Reddy's Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.2.4 Nalbuphine HCL Product Introduction
- 10.2.5 Dr Reddy's Recent Development
- 10.3 Glenmark
- 10.3.1 Glenmark Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.3.4 Nalbuphine HCL Product Introduction
- 10.3.5 Glenmark Recent Development
- 10.4 Global Pharmaceuticals
- 10.4.1 Global Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.4.4 Nalbuphine HCL Product Introduction
- 10.4.5 Global Pharmaceuticals Recent Development
- 10.5 HOSPIRA
- 10.5.1 HOSPIRA Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.5.4 Nalbuphine HCL Product Introduction
- 10.5.5 HOSPIRA Recent Development
- 10.6 Humanwell
- 10.6.1 Humanwell Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.6.4 Nalbuphine HCL Product Introduction
- 10.6.5 Humanwell Recent Development
- 10.7 Incepta Pharmaceuticals
- 10.7.1 Incepta Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.7.4 Nalbuphine HCL Product Introduction
- 10.7.5 Incepta Pharmaceuticals Recent Development
- 10.8 Manusaktteva
- 10.8.1 Manusaktteva Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.8.4 Nalbuphine HCL Product Introduction
- 10.8.5 Manusaktteva Recent Development
- 10.9 Opsonin
- 10.9.1 Opsonin Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.9.4 Nalbuphine HCL Product Introduction
- 10.9.5 Opsonin Recent Development
- 10.10 Sami
- 10.10.1 Sami Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Nalbuphine HCL
- 10.10.4 Nalbuphine HCL Product Introduction
- 10.10.5 Sami Recent Development
- 10.11 Squarepharma
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Nalbuphine HCL Sales Channels
- 11.2.2 Nalbuphine HCL Distributors
- 11.3 Nalbuphine HCL Customers
12 Market Forecast
- 12.1 Global Nalbuphine HCL Sales and Revenue Forecast 2019-2025
- 12.2 Global Nalbuphine HCL Sales Forecast by Type
- 12.3 Global Nalbuphine HCL Sales Forecast by Application
- 12.4 Nalbuphine HCL Forecast by Regions
- 12.4.1 Global Nalbuphine HCL Sales Forecast by Regions 2019-2025
- 12.4.2 Global Nalbuphine HCL Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Nalbuphine HCL. Industry analysis & Market Report on Nalbuphine HCL is a syndicated market report, published as Global (United States, European Union and China) Nalbuphine HCL Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Nalbuphine HCL market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
